Download PDF
Endoscopy 2005; 37(2): 133-138
DOI: 10.1055/s-2004-826150
State of the Art Review
© Georg Thieme Verlag KG Stuttgart · New York

Diagnostic Endoscopic Retrograde Cholangiopancreatography

M.  Häfner1 , R.  Schöfl2
  • 1Dept. of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
  • 2Dept. of Internal Medicine IV, Krankenhaus der Elisabethinen, Linz, Austria
Further Information

Publication History

Publication Date:
03 February 2005 (online)

Also available at
    Permissions and Reprints

Although diagnostic endoscopic retrograde cholangiopancreatography (ERCP) has been replaced in many fields by magnetic resonance cholangiopancreatography (MRCP), considerable amounts of research are still ongoing. Major fields of interest include ways of reducing the incidence of post-ERCP pancreatitis, new ways of improving the yield of tissue sampling, and the diagnosis of sphincter of Oddi dysfunction. In addition, there are new data comparing the diagnostic accuracy of ERCP with that of MRCP and endoscopic ultrasonography.

References

  • 1 Ciocirlan M, Ponchon T. Diagnostic endoscopic cholangiopancreatography.  Endoscopy. 2004;  36 136-146
    PubMedGoogle Scholar
  • 2 Rodríguez-González F JR, Naránjo-Rodríguez A, Mata-Tapia I. et al . ERCP in patients 90 years of age and older.  Gastrointest Endosc. 2003;  58 220-225
    PubMedGoogle Scholar
  • 3 Johnston S D, McKenna A, Tham T CK. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography.  Endoscopy. 2003;  35 1039-1042
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Masci E, Mariani A, Curioni S. et al . Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.  Endoscopy. 2003;  35 830-834
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Hackert T, Werner J, Gebhard M M. et al . Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.  Surgery. 2004;  135 131-138
    CrossrefPubMedGoogle Scholar
  • 6 Rabenstein T, Fischer B, Wiessner V. et al . Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.  Gastrointest Endosc. 2004;  59 606-613
    CrossrefPubMedGoogle Scholar
  • 7 Poon R TP, Yeung C, Liu C L. et al . Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.  Gut. 2003;  52 1768-1773
    CrossrefPubMedGoogle Scholar
  • 8 Arvanitidis D, Anagnostopoulos G K, Giannopoulos D. et al . Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.  J Gastroenterol Hepatol. 2004;  19 278-282
    CrossrefPubMedGoogle Scholar
  • 9 Cavallini G, Tittobello A, Frulloni L. et al . Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in Digestive Endoscopy - Italian Group.  N Engl J Med. 1996;  335 919-923
    CrossrefPubMedGoogle Scholar
  • 10 Masci E, Cavallini G, Mariani A. et al . Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.  Am J Gastroenterol. 2003;  98 2182-2186
    CrossrefPubMedGoogle Scholar
  • 11 Perney P, Berthier E, Pageaux G P. et al . Are drugs a risk factor of post-ERCP pancreatitis?.  Gastrointest Endosc. 2003;  58 696-700
    CrossrefPubMedGoogle Scholar
  • 12 Lella F, Bagnolo F, Colombo E. et al . A simple way of avoiding post-ERCP pancreatitis.  Gastrointest Endosc. 2004;  59 830-834
    CrossrefPubMedGoogle Scholar
  • 13 Fazel A, Quadri A, Catalano M. et al . Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.  Gastrointest Endosc. 2003;  57 291-294
    CrossrefPubMedGoogle Scholar
  • 14 Laasch H U, Tringali A, Wilbraham L. et al . Comparison of standard and steerable catheters for bile duct cannulation in ERCP.  Endoscopy. 2003;  35 669-674
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Sweeney J T, Shah R J, Martin S P. et al . The impact of post-procedure interpretation of ERCP X-ray films by radiologists on patient care: should it be routine or selective?.  Gastrointest Endosc. 2003;  58 549-553
    CrossrefPubMedGoogle Scholar
  • 16 Kowalski T, Kanchana T, Pungpapong S. Perceptions of gastroenterology fellows regarding ERCP competency and training.  Gastrointest Endosc. 2003;  58 345-349
    CrossrefPubMedGoogle Scholar
  • 17 Griffin N, Wastle M L, Dunn W K. et al . Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis.  Eur J Gastroenterol Hepatol. 2003;  15 809-813
    PubMedGoogle Scholar
  • 18 Talwalkar J A, Angulo P, Johnson C D. et al . Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.  Hepatology. 2004;  40 39-45
    CrossrefPubMedGoogle Scholar
  • 19 Hünerbein M, Stroszczynski C, Ulmer C. et al . Prospective comparison of transcutaneous 3-dimensional US cholangiography, magnetic resonance cholangiography, and direct cholangiography in the evaluation of malignant biliary obstruction.  Gastrointest Endosc. 2003;  58 853-858
    CrossrefPubMedGoogle Scholar
  • 20 Seifert H, Wehrmann T, Hilgers R. et al . Catheter probe extraductal EUS reliably detects distal common bile duct abnormalities.  Gastrointest Endosc. 2004;  60 61-67
    CrossrefPubMedGoogle Scholar
  • 21 Meenan J, Tibble J, Prasad P. et al . The substitution of endoscopic ultrasound for endoscopic retrograde cholangiopancreatography: implications for service development and training.  Eur J Gastroenterol Hepatol. 2004;  16 299-303
    PubMedGoogle Scholar
  • 22 Wilcox C M, Linder J. Prospective evaluation of droperidol on sphincter of Oddi motility.  Gastrointest Endosc. 2003;  58 483-487
    CrossrefPubMedGoogle Scholar
  • 23 Fogel E L, Sherman S, Bucksot L. et al . Effects of droperidol on the pancreatic and biliary sphincters.  Gastrointest Endosc. 2003;  58 488-492
    CrossrefPubMedGoogle Scholar
  • 24 Singh P, Gurudu S R, Davidoff S. et al . Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis.  Gastrointest Endosc. 2004;  59 499-505
    CrossrefPubMedGoogle Scholar
  • 25 Mariani A, Curioni S, Zanello A. et al . Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis.  Gastrointest Endosc. 2003;  58 847-852
    CrossrefPubMedGoogle Scholar
  • 26 Varadarajulu S, Hawes R H, Cotton P B. Determination of sphincter of Oddi dysfunction in patients with prior normal manometry.  Gastrointest Endosc. 2003;  58 341-344
    CrossrefPubMedGoogle Scholar
  • 27 Rashdan A, Fogel E, McHenry L. et al . Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction.  Gastrointest Endosc. 2003;  58 875-878
    CrossrefPubMedGoogle Scholar
  • 28 Lin L F, Slauw C P, Ho K S. et al . Guidewire technique for endoscopic transpapillary procurement of bile duct biopsy specimens without endoscopic sphincterotomy.  Gastrointest Endosc. 2003;  58 272-274
    PubMedGoogle Scholar
  • 29 Siddiqui M T, Gokasian S T, Saboorian M H. et al . Comparison of ThinPrep and conventional smears in detecting carcinoma in bile duct brushings.  Cancer. 2003;  99 205-210
    CrossrefPubMedGoogle Scholar
  • 30 Duggan M A, Brasher P, Medlicott S A. ERCP-directed brush cytology prepared by the ThinPrep method: test performance and morphology of 149 cases.  Cytopathology. 2004;  15 80-86
    CrossrefPubMedGoogle Scholar
  • 31 De Bellis M, Fogel E L, Sherman S. et al . Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction.  Gastrointest Endosc. 2003;  58 176-182
    CrossrefPubMedGoogle Scholar
  • 32 Rösch T, Hofrichter K, Frimberger E. et al . ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study.  Gastrointest Endosc. 2004;  60 390-396
    CrossrefPubMedGoogle Scholar
  • 33 Zhou G X, Huang J F, Li Z S. et al . Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.  World J Gastroenterol. 2004;  10 1337-1340
    PubMedGoogle Scholar
  • 34 Arvanitakis M, van Laethem J L, Parma J. et al . Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.  Endoscopy. 2004;  36 535-542
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Inoue K, Ohuchida J, Ohtsuka T. et al . Severe localized stenosis and marked dilatation of the main pancreatic duct are indicators of pancreatic cancer instead of chronic pancreatitis on endoscopic retrograde balloon pancreatography.  Gastrointest Endosc. 2003;  58 510-515
    CrossrefPubMedGoogle Scholar

R. Schöfl, M. D.

Dept. of Internal Medicine IV, Krankenhaus der Elisabethinen

Fadingerstraße 1 · 4020 Linz · Austria

Fax: + 43-732-7676-4446

Email: rainer.schoefl@elisabethinen.or.at

      >